BRIEF

on EBD Group

BIO-Europe Spring 2026 Looks to Lisbon for Life Sciences Innovation

The BIO-Europe Spring 2026 conference will unfold in Lisbon, Portugal, from March 23 to 25, with an additional digital event on March 31 to April 1. This marks the first joint occurrence with LSX Europe during the Life Sciences Spring Innovation Week, creating an invaluable platform for global partnerships.

The event expects over 3,700 participants from across the life sciences sector, including academia, biotech startups, pharmaceutical leaders, and investors. Scheduled are more than 20,000 meetings aimed at fostering strategic collaborations.

Lisbon is recognized for its vibrant life sciences ecosystem, featuring competitive pharmaceutical activity, premier research institutions, and a budding venture capital scene. The BIO-Europe Spring 2026 program promises a diverse array of sessions, such as discussions on biotech partnering, AI in drug development, and global investment trends.

R. P.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all EBD Group news